DalsnaFinance Account

Ceribell Inc $CBLL

Health Care

Russell 2000 California

Create a scorecard

$27.40

+0.26 (+0.96%)

As of Oct 22, 2026, 9:29 PM EDT

Price history

Loading chart…

Ceribell Inc (CBLL) is trading up at $27.40 (+0.96%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: October 11, 2024 · $17.00 offering · NASDAQ · View IPO details →

Ceribell Inc revenue & net income history (FY2023–FY2025)

RevenueNet incomeNet margin (right axis, %)

Ceribell Inc annual financial statements
	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$45.2M	$65.4M	$89.1M
Growth (year over year)	—	+44.7%	+36.1%
Gross profit	$38.2M	$56.8M	$78.3M
Gross margin	84.4%	86.7%	87.9%
Operating income	−$30.0M	−$39.7M	−$58.4M
Operating margin	−66.4%	−60.7%	−65.6%
Net income	−$29.5M	−$40.5M	−$53.4M
Net margin	−65.1%	−61.8%	−60.0%
EPS (diluted)	−$5.56	−$3.39	−$1.46
Balance sheet
Cash and equivalents	$34.5M	$194.4M	$40.5M
Total assets	$58.9M	$225.4M	$195.8M
Total liabilities	$23.8M	$34.2M	$40.5M
Shareholders' equity	−$112.3M	$191.2M	$155.3M
Cash flow
Operating cash flow	−$29.2M	−$35.0M	−$40.8M
Capital expenditure	$983.0K	$1.34M	$767.0K
Free cash flow	−$30.1M	−$36.4M	−$41.6M

RevenueNet incomeNet margin (right axis, %)

Ceribell Inc quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$17.2M	$18.5M	$20.5M	$21.2M	$22.6M	$24.8M	$26.5M	$28.1M
Growth (year over year)	+48.1%	+41.1%	+42.3%	+38.4%	+31.4%	+33.7%	+29.3%	+32.5%
Gross profit	$15.0M	$16.2M	$18.0M	$18.7M	$19.9M	$21.6M	$23.1M	$25.9M
Gross margin	87.3%	87.6%	87.9%	88.1%	88.3%	87.3%	87.3%	92.3%
Operating income	−$9.94M	−$12.9M	−$14.2M	−$15.0M	−$14.6M	−$14.6M	−$20.7M	−$20.0M
Operating margin	−57.8%	−69.5%	−69.3%	−70.5%	−64.8%	−58.9%	−78.3%	−71.1%
Net income	−$10.4M	−$12.6M	−$12.8M	−$13.6M	−$13.5M	−$13.5M	−$19.7M	−$19.3M
Net margin	−60.6%	−67.9%	−62.4%	−64.4%	−59.6%	−54.6%	−74.5%	−68.6%
EPS (diluted)	−$1.85	$1.63	−$0.36	−$0.38	−$0.37	−$0.35	−$0.52	−$0.51
Balance sheet
Cash and equivalents	$14.1M	$194.4M	$153.4M	$40.1M	$23.7M	$40.5M	$45.3M	$32.7M
Total assets	$47.1M	$225.4M	$213.5M	$207.7M	$199.5M	$195.8M	$178.1M	$166.3M
Total liabilities	$35.6M	$34.2M	$32.6M	$35.5M	$35.4M	$40.5M	$37.3M	$38.0M
Shareholders' equity	−$136.0M	$191.2M	$180.9M	$172.2M	$164.1M	$155.3M	$140.8M	$128.3M
Cash flow
Operating cash flow	−$8.54M	−$9.97M	−$11.4M	−$7.53M	−$11.1M	−$10.8M	−$19.3M	−$12.9M
Capital expenditure	$567.0K	$357.0K	$148.0K	$71.0K	$369.0K	$179.0K	$125.0K	$17.0K
Free cash flow	−$9.11M	−$10.3M	−$11.6M	−$7.60M	−$11.5M	−$11.0M	−$19.4M	−$12.9M

From Ceribell Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →